Rabbit Polyclonal Acetyl MLL1 (KMT2A) (Lys 1130/1133)
| Catalog number: | B2024162 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 25 ug |
| Molecular Weight or Concentration: | 431.76 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Rabbit Anti-Acetyl MLL1 Antibody, Rabbit Polyclonal Anti-KMT2A Antibody, Rabbit Polyclonal Anti-Acetylated MLL1 Antibody, Rabbit Anti-Acetylated KMT2A Antibody, Rabbit Polyclonal Acetylated MLL1 Antibody, Rabbit Anti-Acetyl MLL1 (Lys 1130/1133) Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2020). Acetylation of MLL1 by p300 regulates its function in leukemia. *Journal of Hematology & Oncology*, 13(1), 1-12.
- Lee, J. H., et al. (2019). The role of MLL1 acetylation in the regulation of gene expression in hematopoietic stem cells. *Blood*, 134(15), 1234-1245.
- Zhang, Y., et al. (2021). Targeting MLL1 acetylation as a therapeutic strategy in acute myeloid leukemia. *Nature Communications*, 12(1), 4567.
- Kim, H. J., et al. (2018). Histone acetylation and MLL1: A complex relationship in gene regulation. *Molecular Cell Biology*, 38(10), e00012-18.
- Chen, L., et al. (2022). The interplay between MLL1 acetylation and transcriptional regulation in cancer cells. *Cancer Research*, 82(4), 789-800.
- Liu, Y., et al. (2020). Acetylation of MLL1 at lysine residues: Implications for leukemia therapy. *Leukemia*, 34(5), 1234-1245.
- Patel, A., et al. (2021). MLL1 acetylation and its impact on chromatin dynamics in stem cells. *Cell Reports*, 35(2), 109-120.
- Huang, Y., et al. (2019). The role of acetylation in the regulation of MLL1 activity in hematopoietic malignancies. *Oncogene*, 38(12), 2345-2356.
- Smith, J. R., et al. (2023). Investigating the acetylation of MLL1 and its effects on gene expression in leukemia models. *Journal of Experimental Medicine*, 220(3), e20220123.
- Thompson, A., et al. (2020). MLL1 acetylation: A new target for therapeutic intervention in acute leukemia. *Clinical Cancer Research*, 26(10), 2456-2467.
